Infantile-onset Hypophosphatasia

DrugDrug NameDrug Description
DB09105Asfotase alfaAn enzyme replacement therapy used for the treatment of perinatal/infantile and juvenile onset hypophosphatasia (HPP).
DrugDrug NameTargetType
DB09105Asfotase alfaPyrophosphatetarget
DrugDrug NamePhaseStatusCount